During ELRIGfr event in Rennes, We had the opportunity to present our work on genotoxicity assay (comet assay on TK6 & gH2AX on keratinocytes and HepG2) in collaboration with the team of in vitro of Galderma R&D. It is really exciting to work with them since they are really experts in their domain and they want to work on innovative solutions in HCS. We really want to thank them for our interesting discussion and our collaborative projects!
PosterGenotoxHCSPharma-Galderma
We wish you a great year 2021, with great success in your all your projects. Here at HCS Pharma, we strongly believed that 3D cell culture in adequat medium is a key factor for successful Read more…
Step by step we are getting closer to 2021, after a very particular and, for some of us, very difficult 2020 year. 2021 will be THE year of 3D cell culture in many research applications Read more…
Clinicians and researchers worldwide are actively studying the mechanisms governing the infection of humans by SARS-CoV-2 and its consequences on their health, with the objective is to find effective therapies. We all aknowledge their important Read more…
0 Comments